FDA.reportPublic FDA data

Claritin

Manufacturer
Bayer Healthcare LLC.
Effective date
2025-12-05
Label type
HUMAN OTC DRUG LABEL
Version
12
Source
full-release
Hydrated at
2026-06-01 01:20:23

Label at a glance#

ProductClaritin Reditabs
Active ingredientLORATADINE
Label structure12 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Dosage and administration

place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Storage and handling

safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn store between 20° to 25°C (68° to 77°F) use tablet immediately after opening individual blister complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Loratadine 10 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

OTC - STOP USE SECTION

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • place 1 tablet on tongue; tablet disintegrates, with or without water
adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hours
children under 6 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information

STORAGE AND HANDLING SECTION

  • safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn
  • store between 20° to 25°C (68° to 77°F)
  • use tablet immediately after opening individual blister
  • complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration

Inactive ingredients

INACTIVE INGREDIENT SECTION

anhydrous citric acid, gelatin, mannitol, mint flavor

Questions or comments?

OTC - QUESTIONS SECTION

1-800-CLARITIN (1-800-252-7484) or www.claritin.com

SPL UNCLASSIFIED SECTION

Distributed by MSD Consumer Care, Inc.,
PO Box 377, Memphis, TN 38151 USA,
a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Original Prescription Strength
NDC 11523-7157-2

Non-Drowsy*
Claritin ®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itchy Throat
    or Nose

No Water Needed
Melts in Your Mouth

10
ORALLY
DISINTEGRATING TABLETS

PRINCIPAL DISPLAY PANEL - 10 Tablet Carton
PRINCIPAL DISPLAY PANEL - 10 Tablet Carton

PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TWIN PACK

Two 30ct Cartons
60 RediTabs ®

Original Prescription Strength

NDC 11523-4329-1

Non-Drowsy*
Claritin ®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itchy Throat
    or Nose

No Water Needed
Melts in Your Mouth

60
ORALLY
DISINTEGRATING TABLETS

PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton
PRINCIPAL DISPLAY PANEL - 60 Tablet Twin Pack Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
744830Claritin RediTabs 10 MG 24HR Disintegrating Oral TabletPSN12
311373loratadine 10 MG 24HR Disintegrating Oral TabletPSN12
744830loratadine 10 MG Disintegrating Oral Tablet [Claritin]SBD12
311373loratadine 10 MG Disintegrating Oral TabletSCD12
744830Claritin 10 MG Disintegrating Oral TabletSY12
744830Claritin 24HR RediTabs 10 MG Disintegrating Oral TabletSY12

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeITF02719405claritin-01.jpg
Data codeITF02719805claritin-02.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11523-4329-1ClaritinReditabs3 in 1 CARTONTABLET, ORALLY DISINTEGRATING312
11523-4329-1ClaritinReditabs2 in 1 PACKAGE, COMBINATIONTABLET, ORALLY DISINTEGRATING212
11523-4329-2ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-4329-2ClaritinReditabs6 in 1 CARTONTABLET, ORALLY DISINTEGRATING612
11523-7157-2ClaritinReditabs1 in 1 CARTONTABLET, ORALLY DISINTEGRATING112
11523-7157-2ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7157-3ClaritinReditabs3 in 1 CARTONTABLET, ORALLY DISINTEGRATING312
11523-7157-3ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7157-4ClaritinReditabs2 in 1 CARTONTABLET, ORALLY DISINTEGRATING212
11523-7157-4ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7157-7ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7157-7ClaritinReditabs4 in 1 CARTONTABLET, ORALLY DISINTEGRATING412
11523-7157-8ClaritinReditabs5 in 1 CARTONTABLET, ORALLY DISINTEGRATING512
11523-7157-8ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7157-9ClaritinReditabs10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1012
11523-7157-9ClaritinReditabs7 in 1 CARTONTABLET, ORALLY DISINTEGRATING712

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11523-7157-2EA - Each11523-7157128f54a2-0776-4dea-a042-44b6442d3b6912012-07-24
11523-7157-3EA - Each11523-7157fd89b497-47a4-4038-a766-17f963a2870b12012-07-24
11523-7157-8EA - Each11523-7157a461ab26-b1e4-4ea2-86d4-61841d1b15a012012-07-24
11523-4329-1EA - Each11523-4329cf5c942c-756e-460f-b41f-0686f81799e112015-10-02
11523-4329-2EA - Each11523-4329971dca07-9616-4400-b367-5b35cd2c98f412024-04-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LoratadineACTIVE INGREDIENT7AJO3BO7QN4
LoratadineACTIVE MOIETY7AJO3BO7QN4
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSL4
gelatinINACTIVE INGREDIENT2G86QN327L4
mannitolINACTIVE INGREDIENT3OWL53L36A4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11523-715711523-7157-2, 11523-7157-3, 11523-7157-4, 11523-7157-7, 11523-7157-8, 11523-7157-9
11523-432911523-4329-1, 11523-4329-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
NameUNIIKind
MANNITOL3OWL53L36AIACT
LORATADINE7AJO3BO7QNACTIB
ANHYDROUS CITRIC ACIDXF417D3PSLIACT
GELATIN2G86QN327LIACT
ANHYDROUS CITRIC ACIDXF417D3PSLIACT
GELATIN2G86QN327LIACT
MANNITOL3OWL53L36AIACT
LORATADINE7AJO3BO7QNACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 30 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
gelatinGELATIN2G86QN327LTABLET, ORALLY DISINTEGRATING / ORAL120 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
mannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii+route+dosage form
10 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020704-002CLARITIN REDITABSLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27
N020704-003CLARITIN HIVES RELIEF REDITABLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-2784e616aacf4f…
2026-09-14 22:38:342026-08N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-1984e616aacf4f…
2026-08-18 06:07:402026-07N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27caaa826d4ba7…
2026-08-18 06:07:402026-07N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27d06236e962d9…
2024-10-29 15:01 UTC2024-10N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-2779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-27301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-271e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-278072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-275c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-275d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-274b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020704-002CLARITIN REDITABS10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2002-11-2774a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020704-003CLARITIN HIVES RELIEF REDITAB10MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2003-11-1974a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Claritin ReditabsLORATADINEBayer Healthcare LLC.b681ea25-d00b-4c8a-8054-cc6f983ce3372025-12-05WarningsExact identifier
ndc (package): 11523-7157-3
ndc (package): 11523-4329-2
ndc (package): 11523-4329-1
ndc (package): 11523-7157-7
ndc (package): 11523-7157-4
ndc (package): 11523-7157-9
ndc (package): 11523-7157-2
ndc (package): 11523-7157-8
ndc (product): 11523-4329
ndc (product): 11523-7157
ndc11 (package): 11523715708
ndc11 (package): 11523432902
ndc11 (package): 11523715709
ndc11 (package): 11523715702
ndc11 (package): 11523432901
ndc11 (package): 11523715707
ndc11 (package): 11523715703
ndc11 (package): 11523715704
spl id: 4536fe84-5b46-ca4c-e063-6394a90ad03a
spl set id: b681ea25-d00b-4c8a-8054-cc6f983ce337

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.